|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
|
CA2133439C
(en)
|
1992-04-02 |
2005-07-26 |
Siegfried Benjamin Christensen, Iv |
Compounds useful for treating allergic and inflammatory diseases
|
|
AU679511B2
(en)
|
1993-03-17 |
1997-07-03 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
|
SI0765308T1
(sl)
|
1994-06-15 |
2000-08-31 |
The Wellcome Foundation Limited |
Encimski inhibitorji
|
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
|
WO1999016766A1
(en)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Benzodioxole derivatives
|
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
AU3328499A
(en)
|
1998-03-14 |
1999-10-11 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phthalazinone pde iii/iv inhibitors
|
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
WO2000066590A2
(en)
|
1999-05-04 |
2000-11-09 |
Ligand Pharmaceuticals, Inc. |
Tetracyclic progesterone receptor modulator compounds and methods
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
|
PT1305329E
(pt)
|
2000-08-05 |
2007-12-24 |
Glaxo Group Ltd |
Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-(2-furanilcarboxil)oxi-11.beta.-hidroxi-16.alfa.-metil- 3-oxo-androsta-1,4-dieno-17-carbotióico como um agente antiinflamatório
|
|
CA2423251A1
(en)
|
2000-09-29 |
2002-04-04 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP2004526720A
(ja)
|
2001-03-08 |
2004-09-02 |
グラクソ グループ リミテッド |
βアドレナリン受容体のアゴニスト
|
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
|
MY137522A
(en)
|
2001-04-30 |
2009-02-27 |
Glaxo Group Ltd |
Novel anti-inflammatory androstane derivatives.
|
|
ES2307751T3
(es)
|
2001-06-12 |
2008-12-01 |
Glaxo Group Limited |
Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
|
|
RU2312854C2
(ru)
|
2001-09-14 |
2007-12-20 |
Глаксо Груп Лимитед |
Производные фенэтаноламина для лечения респираторных заболеваний
|
|
DE60235114D1
(de)
*
|
2001-11-01 |
2010-03-04 |
Icagen Inc |
Pyrazolamide zur anwendung in der behandlung von schmerz
|
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
|
ATE346058T1
(de)
|
2002-01-14 |
2006-12-15 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
|
|
AU2003214879B2
(en)
|
2002-01-22 |
2008-02-07 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
|
HRP20040887A2
(en)
|
2002-03-26 |
2005-04-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7268152B2
(en)
|
2002-03-26 |
2007-09-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
ATE496620T1
(de)
|
2002-04-11 |
2011-02-15 |
Merck Sharp & Dohme |
1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
|
|
DE60318193T2
(de)
|
2002-04-25 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Phenethanolaminderivate
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
AU2003281355A1
(en)
|
2002-07-08 |
2004-01-23 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
AU2003251970A1
(en)
|
2002-07-18 |
2004-02-09 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
CA2496175A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
|
MXPA05002887A
(es)
|
2002-09-16 |
2005-05-27 |
Glaxo Group Ltd |
Compuestos de pirazolo[3,4-b]piridina, y su uso como inhibidores de fosfodiesterasa.
|
|
EP1542996A4
(en)
|
2002-09-20 |
2009-11-18 |
Merck & Co Inc |
OCTAHYDRO-2H-NAPHTOc1,2-F INDOL-4-CARBONSUUREAMIDE DERIVATIVES AS SELECTIVE MODULATORS OF THE GLUCOCORTICOID RECEPTOR
|
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2003298094A1
(en)
|
2002-10-22 |
2004-05-13 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
EP1556342B1
(en)
|
2002-10-28 |
2008-03-26 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
PL1699512T3
(pl)
|
2003-11-03 |
2012-11-30 |
Glaxo Group Ltd |
Urządzenie do dozowania płynów
|
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
|
BRPI0518222A
(pt)
|
2004-10-19 |
2008-11-04 |
Hoffmann La Roche |
composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos
|
|
EP1833795B1
(en)
|
2004-12-23 |
2009-03-04 |
Glaxo Group Limited |
Pyridine compounds for the treatment of prostaglandin mediated diseases
|
|
EP1841780B1
(en)
|
2005-01-10 |
2011-07-27 |
Glaxo Group Limited |
Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
|
US20090124588A1
(en)
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
|
ES2414479T3
(es)
|
2005-04-14 |
2013-07-19 |
Glaxo Group Limited |
Indazoles como ligandos del receptor de glucocorticoides
|
|
GB0513297D0
(en)
|
2005-06-29 |
2005-08-03 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0522880D0
(en)
|
2005-11-09 |
2005-12-21 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2421834A1
(en)
*
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
US20100273744A1
(en)
|
2009-04-24 |
2010-10-28 |
Paul Martin Gore |
Compounds
|
|
EP2630126B1
(en)
*
|
2010-10-21 |
2015-01-07 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, immune and inflammatory conditions
|